CAMBRIDGE, Mass., March 30, 2020 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines called Synthetic...
Health and medicine
SynBioBeta State of the Industry Town Hall with Drew Endy
Drew Endy is a member of the bioengineering faculty at Stanford University and BioBricks Foundation president (biobricks.org). His research teams pioneered amplifying genetic logic, rewritable DNA data storage, reliably...
